Effect of Meal Composition and Timing Modification on Glucose Metabolism, Body Temperature and Sleep
Launched by STANFORD UNIVERSITY · Jun 7, 2022
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how changing the timing and composition of meals affects blood sugar levels, metabolism, body temperature, and sleep in people with prediabetes, type 2 diabetes, and those who are generally healthy. Researchers want to understand how different meals can impact these factors, which could help improve health for those with diabetes or at risk of developing it.
To participate in this study, you need to be at least 18 years old and generally healthy, or have prediabetes or type 2 diabetes that is managed either through diet or with the medication metformin. Women who are pregnant or breastfeeding cannot join. If you decide to participate, you’ll be asked to give your consent and follow certain study procedures. This study is currently recruiting participants, so if you're interested, it could be a chance to contribute to important research that may benefit many people with similar health conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Be 18 years of age or older;
- • Not be pregnant, if female;
- • Be generally healthy (with no apparent symptoms at the time of enrollment)
- • Patients with prediabetes or diet- controlled or type 2 diabetes or controlled with metformin, will also be allowed to participate.
- • Be willing to provide written informed consent for all study procedures.
- Exclusion Criteria:
- • major organ disease
- • pregnant/lactating
- • diabetes medications except for metformin
- • malabsorptive disorders like celiac sprue
- • heavy alcohol use
- • use of weight loss medications or specific diets
- • weight change \>2 Kg in the last month
- • history of bariatric surgery
- • Any medical condition that physicians believe would interfere with study participation or evaluation of results
- • Mental incapacity and/or cognitive impairment on the part of the patient that would preclude adequate understanding of, or cooperation with, the study protocol.
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stanford, California, United States
Patients applied
Trial Officials
Michael Snyder, PhD
Principal Investigator
Stanford University
Heyjun Park, PhD
Study Director
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials